Last updated on February 2019
MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
Brief description of study
This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) plus metronidazole, compared with that of meropenem in pediatric participants with cIAI.
Clinical Study Identifier: NCT03217136
Start Over
Study Coordinator
Universiti Kebangsaan Malaya Medical Centre ( Site 1101) Cheras, Malaysia3.86miles
Connect »
Study Coordinator
University Malaya Medical Centre. ( Site 1100) Kuala Lumpur, Malaysia5.26miles
Connect »